Polio Vaccine Group
Table of Contents
- 1 Polio Vaccine Group Evaluation and Forecasting Rules
- 1.1 General Rules for Polio
- 1.1.1 Rules Based on Patient's Age
- 1.1.2 Notes
- 1.2 Polio Vaccines
- 1.3 Combination Vaccines that Include Polio
- 1.3.1 CVX Code Specific Rules
- 1.3.1.1 Rule for CVX 178 and CVX 179
- 1.3.1.2 Rule for CVX 02 and CVX 182
- 1.3.1.3 Rule for CVX 89
- 1.3.1 CVX Code Specific Rules
- 1.4 Immunization Series and Selection Rules
- 1.4.1 Series Name
- 1.4.2 Series Selection Rules
- 1.5 Immunization Series: Polio 4-dose Series
- 1.5.1 Series Special Rules
- 1.5.1.1 4-dose Series Exception Rules
- 1.5.1.2 CVX 324 Rule
- 1.5.2 Installation Configuration Option
- 1.5.3 Notes
- 1.5.1 Series Special Rules
- 1.6 Immunization Series: Polio fractional IPV (fIPV) Series
- 1.6.1 Series Special Rules
- 1.6.1.1 fIPV Series Exception Rules
- 1.6.2 Installation Configuration Option
- 1.6.3 Notes
- 1.6.1 Series Special Rules
- 1.1 General Rules for Polio
Polio Vaccine Group Evaluation and Forecasting Rules
Clinical Guidelines
These rules align with guidance issued by ACIP/CDC and AAP/AAFP.
See ICE Default Immunization Schedule: Clinical Guidelines for more information.
General Rules for Polio
General rules are not series-specific; general rules apply to the entire vaccine group.
Rules Based on Patient's Age
If a patient is >=18 years old and has no shots on record:
the recommendation is Conditional, with recommendation reasons HIGH_RISK and SUPPLEMENTAL_TEXT; Descriptive Text: "Unless there are specific reasons to believe they were not vaccinated, most adults who were born and raised in the United States can assume they were vaccinated against polio as children. Refer to ACIP for additional information."
If a patient is >= 18 years old and has completed the series:
the recommendation is Conditional, with recommendation reasons COMPLETE_HIGH_RISK and SUPPLEMENTAL_TEXT; Descriptive Text: "Adults who completed their polio vaccination but who are at increased risk of exposure to poliovirus may receive one lifetime IPV booster. Refer to ACIP for additional information."
and is administered shot(s) after series completion:
and those shot(s) are administered at <18 years old:
evaluate those shot(s) as Accepted/ EXTRA_DOSE. This evaluation applies regardless of CVX Code Specific Rules - Rule for CVX 178 and CVX 179 and Rule for CVX 02 and CVX 182 below.
and those shot(s) are administered at >= 18 years old:
evaluate the first shot administered as Valid / BOOSTER_DOSE (i.e., if CVX Code Specific Rules are met); Absolute Minimum interval (from previous shot) = 0 days.1
evaluate all shot(s) administered afterwards as Accepted/ EXTRA_DOSE. This evaluation applies regardless of CVX Code Specific Rules - Rule for CVX 178 and CVX 179 and Rule for CVX 02 and CVX 182 below.
and has received one booster dose after series completion, recommendation = Not Recommended/ COMPLETE.
Notes
1 For shots administered at the Absolute Minimum interval (from previous shot) of 0 days, ICE General Rule #27 - Two Shots, Same Vaccine Group, Same Day applies.
Polio Vaccines
CVX Code | Name |
|---|---|
02 | OPV, trivalent |
10 | IPV |
89 | Polio, unspecified formulation (NOS) |
178 | OPV, bivalent |
179 | OPV, monovalent, unspecified (NOS) |
182 | OPV, Unspecified (NOS) |
324 | Poliovirus, inactivated, fractional-dose (fIPV) |
Combination Vaccines that Include Polio
CVX Code | Vaccine Name | Component | Component |
|---|---|---|---|
110 | DTaP/HepB/IPV | 10 | IPV |
120 | DTaP/IPV/Hib | 10 | IPV |
130 | DTaP/IPV | 10 | IPV |
132 | DTaP-IPV-Hib-Hep B, historical | 10 | IPV |
146 | DTaP, IPV, Hib, Hep B | 10 | IPV |
170 | DTaP-IPV-Hib | 10 | IPV |
195 | DT-IPV adsorbed Non-US | 10 | IPV |
CVX Code Specific Rules
Rule for CVX 178 and CVX 179
If a patient receives CVX 178 or CVX 179, evaluate these shots as Invalid with reason code MISSING_ANTIGEN.
Ignore the reported shot when determining the recommended due date for the next target dose due and when evaluating the next shot based on the absolute minimum interval for that target dose. (Note - The ICE General Rule "Earliest, recommended, and past due dates must be on or after the last shot given" applies here.)
Rule for CVX 02 and CVX 182
If a patient receives CVX 02 or CVX 182 administered >= 4/1/2016, these shots do not count towards the series. Evaluate these shots as Invalid with reason code MISSING_ANTIGEN.
If the shot administered is CVX 182, ignore the reported shot when determining the recommended due date for the next target dose due and when evaluating the next shot based on the absolute minimum interval for that target dose. (Note - The ICE General Rule "Earliest, recommended, and past due dates must be on or after the last shot given" applies here.)
Rule for CVX 89
If CVX 89 was administered >= 4/1/2016, return reason code SUPPLEMENTAL_TEXT and descriptive text: “CVX 89 represents an unspecified formulation vaccine. Trivalent oral polio vaccine ceased to be used globally in April 2016. If the patient received bivalent or monovalent oral polio vaccine (bOPV or mOPV), additional protection is needed."
Immunization Series and Selection Rules
Series Name
Polio 4-dose Series
Polio fIPV Series
Series Selection Rules
There are two series for this vaccine group: the Polio 4-dose Series and the Polio fIPV Series. The rules for determining which series applies are:
If CVX 324 is administered for dose 1 and dose 2, then the Polio fIPV Series applies.
Otherwise, the Polio 4-dose Series applies.
Immunization Series: Polio 4-dose Series
The Polio 4-dose series is complete after 4 or 5 doses.
Vaccine Dose Parameters - Minimum and Routine Ages
Dose | Series Name | Absolute Minimum Age | Minimum Age2 | Routine Age | Latest Recommended Age (less than) | Valid CVX Code(s) per Dose for this Series |
|---|---|---|---|---|---|---|
1 | Polio 4-dose | 38 days | 42 days (6 weeks) | 2 months | 3 months + 4 weeks | 02, 10, 89, 110, 120, 130, 132, 146, 170, 182, 195 |
2 | Polio 4-dose | 66 days | 70 days (10 weeks) | 4 months | 5 months + 4 weeks | 02, 10, 89, 110, 120, 130, 132, 146, 170, 182, 195 |
3 | Polio 4-dose | 94 days | 98 days (14 weeks) | 6 months | 19 months + 4 weeks | 02, 10, 89, 110, 120, 130, 132, 146, 170, 182, 195 |
43 | Polio 4-dose | 122 days if dose 4 administered < 8/7/2009 4 years - 4 days if dose 4 administered >= 8/7/2009 | 126 days if dose 4 administered < 8/7/2009 4 years if dose 4 administered >= 8/7/2009 | 4 years | 7 years + 4 weeks | 02, 10, 89, 110, 120, 130, 132, 146, 170, 182, 195 |
53 | Polio 4-dose | 4 years - 4 days | 4 years | 4 years | 7 years + 4 weeks | 02, 10, 89, 110, 120, 130, 132, 146, 170, 182, 195 |
Vaccine Dose Parameters - Minimum and Recommended Intervals
Doses | Series Name | Absolute Minimum Interval | Minimum Interval2 | Recommended Interval | Latest Recommended Interval (less than) |
|---|---|---|---|---|---|
Dose 1 to 2 | Polio 4-dose | 24 days | 28 days | 28 days | 13 weeks |
Dose 2 to 3 | Polio 4-dose | 24 days | 28 days | 28 days | 15 months + 4 weeks |
Dose 3 to 4 | Polio 4-dose | 24 days if dose 4 was administered before 8/7/2009 6 months minus 4 days if dose 4 was administered >= 8/7/2009 | 28 days if dose 4 was administered before 8/7/2009 6 months if dose 4 was administered >= 8/7/2009 | 6 months | 6 years + 4 weeks |
Dose 4 to 53 | Polio 4-dose | 6 months minus 4 days | 6 months | 6 months | 6 years + 4 weeks |
Series Special Rules
4-dose Series Exception Rules
The series is complete with 4 doses unless:
Series complete with 3 doses:
If patient is >= 4 years old (or will be >= 4 years old at the dose 3 recommended due date), recommend target dose 3 (and final dose) at 4 years old; recommended interval = 6 months. (Minimum interval= 6 months; absolute minimum interval = 6 months - 4 days)
If dose 3 was administered when the patient was >= 4 years - 4 days old and was administered at least 6 months - 4 days after the previous dose, then the series is complete with 3 doses.
Series complete with 5 doses: (See also Installation Configuration Option)
For children who received target dose 4 at >= 8/7/2009 and before 4 years - 4 days of age:
Evaluate target dose 4 as Valid (i.e., if CVX per dose and CVX code specific rules are met), with reason code EXTRA_DOSE. Absolute minimum interval from dose 3 = 0 days.
An additional dose (target dose 5) is needed to complete the series. See rules in tables above for Dose 5 and Dose 4 to 5.
CVX 324 Rule
If a patient receives shots of CVX 324 administered, these shots do not count towards the series. Evaluate these shots as Invalid/VACCINE_NOT_PART_OF_THIS_SERIES.
Installation Configuration Option
Notes
2 When calculating the target dose 4 Earliest Date in the Polio 4-dose Series:
If Execution Date < 8/7/2009:
Minimum Age: 126 days
Minimum Interval: 28 days
However, if the calculated Earliest Date is >= 8/7/2009, use Minimum Age and Minimum Interval below (4 years, 6 months)
If Execution Date >= 8/7/2009:
Minimum Age: 4 years
Minimum Interval: 6 months
3 The series may be completed with 5 doses for children who received target dose 4 at >= 8/7/2009 and before 4 years - 4 days of age.
In rare circumstances, when the Overdue Date calculation results in a date that is earlier than the Recommended Due Date, ICE will set the Overdue Date to be equal to the Recommended Due Date. Here's an example test scenario:
Patient has 3 doses on record and Dose 3 was given on 1/1/2008 (at 8 years old).
Target Dose 4 Overdue Date would be calculated as Dose 3 + Latest Minimum Interval (28 days) = 1/29/2008.
Recommended Due Date would be calculated as Dose 3 + Recommended Interval (6 months) = 7/1/2008.
Since the Overdue Date results in a date that is earlier than the Recommended Due Date, ICE will set the Overdue Date to be equal to the Recommended Due Date. So adjusted Overdue Date will be set to 7/1/2008.
Immunization Series: Polio fractional IPV (fIPV) Series
The Polio fractional IPV (fIPV) series is complete after 5 or 6 doses.
Vaccine Dose Parameters - Minimum and Routine Ages
Dose | Series Name | Absolute Minimum Age | Minimum Age4 | Routine Age | Latest Recommended Age (less than) | Valid CVX Code(s) per Dose for this Series |
|---|---|---|---|---|---|---|
1 | Polio fIPV | 38 days | 42 days (6 weeks) | N/A | N/A | 324 |
2 | Polio fIPV | 38 days | 42 days (6 weeks) | 2 months | 3 months + 4 weeks | 324 |
3 | Polio fIPV | 66 days | 70 days (10 weeks) | 4 months | 5 months + 4 weeks | 02, 10, 89, 110, 120, 130, 132, 146, 170, 182, 195 |
4 | Polio fIPV | 94 days | 98 days (14 weeks) | 6 months | 19 months + 4 weeks | 02, 10, 89, 110, 120, 130, 132, 146, 170, 182, 195 |
55 | Polio fIPV | 122 days if dose 5 administered < 8/7/2009 4 years - 4 days if dose 5 administered >= 8/7/2009 | 126 days if dose 5 administered < 8/7/2009 4 years if dose 5 administered >= 8/7/2009 | 4 years | 7 years + 4 weeks | 02, 10, 89, 110, 120, 130, 132, 146, 170, 182, 195 |
65 | Polio fIPV | 4 years - 4 days | 4 years | 4 years | 7 years + 4 weeks | 02, 10, 89, 110, 120, 130, 132, 146, 170, 182, 195 |
Vaccine Dose Parameters - Minimum and Recommended Intervals
Doses | Series Name | Absolute Minimum Interval | Minimum Interval4 | Recommended Interval | Latest Recommended Interval (less than) |
|---|---|---|---|---|---|
Dose 1 to 2 | Polio fIPV | 24 days | 28 days | 28 days | 13 weeks |
Dose 2 to 3 | Polio fIPV | 24 days | 28 days | 28 days | 15 months + 4 weeks |
Dose 3 to 4 | Polio fIPV | 24 days | 28 days | 28 days | 15 months + 4 weeks |
Dose 4 to 5 | Polio fIPV | 24 days if dose 5 was administered before 8/7/2009 6 months minus 4 days if dose 5 was administered >= 8/7/2009 | 28 days if dose 5 was administered < 8/7/2009 6 months if dose 5 was administered >= 8/7/2009 | 6 months | 6 years + 4 weeks |
Dose 5 to 65 | Polio fIPV | 6 months minus 4 days | 6 months | 6 months | 6 years + 4 weeks |
Series Special Rules
fIPV Series Exception Rules
The series is complete with 5 doses unless:
Series complete with 4 doses:
If patient is >= 4 years old (or will be >= 4 years old at the dose 4 recommended due date), recommend target dose 4 (and final dose) at 4 years old; recommended interval = 6 months. (Minimum interval= 6 months; absolute minimum interval = 6 months - 4 days)
If dose 4 was administered when the patient was >= 4 years - 4 days old and was administered at least 6 months - 4 days after the previous dose, then the series is complete with 4 doses.
Series complete with 6 doses: (See also Installation Configuration Option)
For children who received target dose 5 at >= 8/7/2009 and before 4 years - 4 days of age: